Table 4.
CD10 | CK7 | AMACR | CD15 | Pax8 | EMA | |
---|---|---|---|---|---|---|
MTSCC | 3/10 (30%) | 10/10(100%) | 10/10 (100%) | 6/10 (60%) | 10/10 (100%) | 9/10 (90%) |
PRCC | 9/13 (69%) | 13/13 (100%) | 13/13 (100%) | 7/10 (70%) | 13/13 (100%) | 8/10 (80%) |
CD10 | CK7 | AMACR | CD15 | Pax8 | EMA | |
---|---|---|---|---|---|---|
MTSCC | 3/10 (30%) | 10/10(100%) | 10/10 (100%) | 6/10 (60%) | 10/10 (100%) | 9/10 (90%) |
PRCC | 9/13 (69%) | 13/13 (100%) | 13/13 (100%) | 7/10 (70%) | 13/13 (100%) | 8/10 (80%) |